SciELO - Scientific Electronic Library Online

 
vol.30 número6Acontecimientos adversos en Medicina Intensiva: Gestionando el riesgo índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Medicina Intensiva

versión impresa ISSN 0210-5691

Resumen

MORA-ORDONEZ, J.M. et al. Use of methylene blue in the treatment of vasoplegic syndrome of post-operative heart surgery. Med. Intensiva [online]. 2006, vol.30, n.6, pp.293-296. ISSN 0210-5691.

Vasoplegia is a frequent complication in post-operative heart surgery and determines a significant increase in morbidity-mortality. When vasoplegia persists in spite of optimized fluid therapy with the use of Swan-Ganz catheter, we have a safe, effective and economical alternative, methylene blue. We present the case of a patient who developed vasoplegia refractory to treatment and shock in the scheduled post-operative period of myocardial revascularization. The use of a single dose of methylene blue resolved the hemodynamic instability and allowed for total discontinuation of vasoactive drugs. Thus, we present this new indication of methylene blue, still not approved by the corresponding bodies, for which no national publications have been found and its clinical management and the absence of adverse effects after its use.

Palabras clave : methylene blue; vasoplegia; shock; cardiopulmonary bypass.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons